Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
gene sequencing
MedTech
Genes hold disease clues, but screening anomalies raise fears
Genetic testing can unsettle some patients, because many findings are ambiguous, and can leave doctors uncertain about whether a variant is dangerous.
Christina Bennett, Kaiser Health News
Feb 9, 2021 9:50am
Regeneron scientists link genes to COVID-19 outcomes
Oct 28, 2020 5:30pm
10x Genomics posts 67% growth in Q3, its first report since IPO
Nov 8, 2019 11:13am
A map of liver cells provides insights into NASH
Aug 8, 2019 11:00am
Thermo Fisher launches 'smart' PCR system line
Apr 16, 2019 11:42am
FDA starts speedy review of Loxo’s larotrectinib
May 29, 2018 9:59am
